Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for Mitochondrial Function in Type 1 Diabetes (T-St1M)
NCT04449198Phase 1Recruiting
- Sponsor
- Augusta University
- Start
- Oct 2020
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of resveratrol in type 1 diabetes mellitus (T1D), sponsored by Augusta University. Primary endpoint: Change in Area Under the Curve for Endothelin-1 and BQ-123 at 12 weeks. Started Oct 2020; status: recruiting.
02
Drugs
resveratrol
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04449198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449198.